Sectoral Asset Management Inc Allakos Inc. Transaction History

Sectoral Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.18 $30,531 - $56,448	-17,751 Reduced 2.3%	752,381 $2.05 Million
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $715,300 - $1.86 Million	335,822 Added 77.32%	770,132 $1.75 Million
Q2 2023 Aug 11, 2023	BUY	$3.6 - $5.25 $1.56 Million - $2.28 Million	434,310 New	434,310 $1.89 Million
Q3 2020 Nov 13, 2020	SELL	$66.43 - $90.99 $245,791 - $336,663	-3,700 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$44.04 - $80.69 $162,948 - $298,553	3,700 New	3,700 $266,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.